Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.26% | -18.69% | -22.09% | -24.38% | -73.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.26% | -18.69% | -22.09% | -24.38% | -73.29% |
| Cost of Revenue | 10.23% | -12.75% | -22.56% | -21.94% | -77.96% |
| Gross Profit | -8.07% | -26.83% | -21.47% | -27.30% | -63.17% |
| SG&A Expenses | 7.24% | -3.99% | -0.53% | -4.84% | -47.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -10,741.18% | -551.07% | -183.68% | -135.67% | -101.77% |
| Total Operating Expenses | 6.55% | -10.35% | -15.63% | -18.04% | -70.07% |
| Operating Income | -120.88% | -1,688.16% | -121.77% | -121.29% | -113.58% |
| Income Before Tax | 210.65% | 225.11% | 240.02% | 50.52% | -250.64% |
| Income Tax Expenses | 285.58% | 217.36% | 292.25% | 173.44% | -235.39% |
| Earnings from Continuing Operations | 204.73% | 226.38% | 231.85% | -22.15% | -251.99% |
| Earnings from Discontinued Operations | 543.72% | -- | -69.72% | -81.90% | -81.90% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 252.90% | 233.86% | 433.14% | -117.46% | -194.76% |
| EBIT | -120.88% | -1,688.16% | -121.77% | -121.29% | -113.58% |
| EBITDA | -83.53% | -122.12% | -78.18% | -90.39% | -98.83% |
| EPS Basic | 257.32% | 248.95% | 539.88% | -84.83% | -185.97% |
| Normalized Basic EPS | 196.98% | 191.12% | 194.29% | 103.88% | -323.91% |
| EPS Diluted | 257.32% | 248.95% | 601.67% | -85.73% | -184.58% |
| Normalized Diluted EPS | 196.98% | 191.12% | 194.29% | 103.88% | -323.91% |
| Average Basic Shares Outstanding | 9.86% | -11.55% | -6.83% | -6.15% | -2.68% |
| Average Diluted Shares Outstanding | 9.86% | -11.55% | -6.83% | -6.15% | -2.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |